The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of prior systemic therapy on lymphocytic infiltration in surgically resected breast cancer brain metastases.
 
Andrew Bacotti
No Relationships to Disclose
 
Rui Wang
No Relationships to Disclose
 
Allison Mary Deal
No Relationships to Disclose
 
Grace Prince
No Relationships to Disclose
 
Megan Jean McKee
No Relationships to Disclose
 
Stergios J. Moschos
Consulting or Advisory Role - Amgen; Castle Biosciences; Merck Sharp & Dohme; Prometheus
Research Funding - Amgen; Genentech/Roche; Merck Sharp & Dohme; Pharmacyclics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
 
Edi Brogi
No Relationships to Disclose
 
Aki Morikawa
Research Funding - Genentech/Roche (Inst); Lilly (Inst); Merrimack (Inst); Novartis (Inst)
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Andrew David Seidman
Honoraria - Eisai; Genentech; Genomic Health; Nektar; Novartis; Odonate Therapeutics; Pfizer
Consulting or Advisory Role - Eisai; Genentech; Merrimack; Nektar; Odonate Therapeutics; Pfizer
Speakers' Bureau - Eisai; Genentech; Genomic Health; Novartis; Pfizer
Research Funding - Bayer (Inst); Nektar (Inst); Novartis (Inst); Odonate Therapeutics (Inst)